Thema: US0311621009
Amgen, US0311621009
Amgen Inc. (ISIN US0311621009) inspirierte dieses geometrische Bauhaus-Poster mit dem Sektor-Schriftzug BIOTECH - Foto: THN
Amgen stock faces a margin test ahead of November 3 results
Amgen stock enters the third-quarter reporting week with higher spending in focus. Growth brands must offset biosimilar pressure on legacy products.
ad-hoc-news.de, heute 11:25 Uhr
Amgen, US0311621009
Amgen stock: Q3 date adds a fresh catalyst before November ...
Amgen stock trades at EUR 413.03 in Berlin on October 29. The company will report third-quarter results on November 3 after the U.S. market close.
ad-hoc-news.de, 29.10.26 17:51 Uhr
Amgen, US0311621009
Amgen presents Sjogren data: Amgen stock gets a 1.8-point ...
Amgen's OASIZ-301 data show a 1.8-point placebo gap at Week 48. A December 11, 2026 payout date gives Amgen stock a second dated event.
ad-hoc-news.de, 28.10.26 11:18 Uhr
Amgen, US0311621009
Jefferies lifts target for Amgen stock to USD 428.00
Amgen reported USD 10.05 billion revenue in the second quarter. Amgen stock costs EUR 401.40 on October 27, 2026, up 1.68 percent versus Xetra close.
ad-hoc-news.de, 27.10.26 16:05 Uhr
Amgen, US0311621009
Amgen reports 58 percent result as Oppenheimer raises target ...
Oppenheimer raised its target from USD 450.00 to USD 480.00 on October 23, 2026. Amgen stock has third-quarter results scheduled for November 3, 2026.
ad-hoc-news.de, 27.10.26 11:13 Uhr
Amgen, US0311621009
Barclays raises target for Amgen stock from USD 380.00 to ...
Q2 revenue hit USD 10.05 billion on June 30, 2026. Amgen stock costs EUR 393.95 on October 26, 2026, down 1.71 percent versus Xetra close.
ad-hoc-news.de, 26.10.26 16:58 Uhr
Amgen, US0311621009
Amgen reports 58 percent lower death risk in trial for Amgen ...
Imdelltra cut death risk 58.00 percent in a Phase 3 trial. Amgen stock was EUR 395.63 on October 26, 2026, with USD 237.5 billion value.
ad-hoc-news.de, 26.10.26 11:06 Uhr
Amgen, US0311621009
Amgen stock: UBS keeps Buy rating ahead of the Xetra open ...
Amgen’s investor calendar lists a Q3 2026 earnings call for November 3, 2026. At Lang & Schwarz the stock trades pre-market at EUR 393.73 on October 26, 2026.
ad-hoc-news.de, 26.10.26 08:26 Uhr
Amgen, US0311621009
Amgen reports 58 percent lower death risk in lung cancer ...
Amgen reported an October 24 lung cancer update. Amgen stock was EUR 392.10 at Lang & Schwarz at 5:21 p.m. CEST on October 25, 2026.
ad-hoc-news.de, 25.10.26 17:24 Uhr
Amgen, US0311621009
Amgen reports Tezspire trial results. Amgen stock trades ...
